Search

everythinglearnresearchcommunity

for

Search:↓

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

A woman was diagnosed with Sheehan's syndrome and a rare complication of diabetes insipidus 33 years after symptoms began, improving with hormone therapy.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Evening primrose oil significantly improves hormone levels and reduces BMI and cholesterol in women with PCOS.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Women with PCOS have higher levels of certain hormones compared to healthy women, and these levels vary with BMI, age, and treatment type.

Skin symptoms like fragile skin and easy bruising can indicate Cushing's syndrome, which requires early diagnosis and treatment to prevent serious health issues.

A man with Klinefelter syndrome had a leg ulcer that didn't heal well, even with treatment.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Diet changes hormone levels in pregnant ewes by affecting metabolism, not placental synthesis.

Acromegaly can be hard to diagnose in young women with atypical symptoms, and persistent high phosphate levels should lead to growth hormone testing.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Silymarin and metformin together most improved hormone levels and ovulation in women with PCOS.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Acute illnesses like sepsis can disrupt thyroid hormone balance without central hypothyroidism.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Thyroid hormone imbalances can cause hair loss in alopecia patients.

Laparoscopic ovarian drilling helps infertile women with PCOS by improving menstrual regularity, ovulation, and chances of conception, and by changing hormone levels.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Metformin reduces certain hormone levels in men with early-onset hair loss.